Silicon Valley Bank (SVB) provided the financing.
The working capital line of credit can be used for general corporate purposes and to support growth.
Led by Eric Marcotulli, co-founder and CEO, Elysium Health works directly scientists and clinicians to translate advances in science and technology into scientifically-sound products that can help people manage their health in an actionable way.
The facility follows a $20m Series B financing the company announced in December 2016. Investors in Elysium include General Catalyst, Breyer Capital, Morningside Venture, Sound Ventures, Jim Manzi (chairman, Thermo Fisher Scientific Inc. and former chairman, president and CEO of Lotus Development Corp), biotech venture capitalist Robert Nelsen, and entrepreneur Matthew Mullenweg.
FinSMEs
29/06/2017